chevyguy, I can't help but wonder what the fascination is with Peregrine's dealing with the Fargo Fiasco. Everyone knows that it was caused by a third party loser with undetermined motivation. Peregrine dealt with it very successfully, which has resulted in the fast moving Sunrise Phase III trial.
I like to look forward to Peregrine's prospects to move Bavi into indications other than NSCLC. I like to look forward to results from Bavi's "dozens of collaborations" as cited in the ASM.
Why look back, when the future is much more interesting?
As to Chris Keenan, I am not a fan. However, I am not invested in Chris Keenan. I am invested in Bavituximab's future. I believe it could help millions of sick people and make me thousands of dollars.
GLTA, Paul